Putting the brakes on an enzyme might rescue neurons that are dying in Parkinson's disease, stabilizing the progression of ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.

Researchers have uncovered another piece of the Parkinson’s disease puzzle, identifying that particular immune cells are ...

Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...

Scientists have discovered that earwax may hold clues to early Parkinson's detection. Analyzing volatile organic compounds ...

LJI scientists have discovered that T cells may help detect Parkinson's disease years before motor symptoms appear. Your T ...

Misbehaving T cells light up long before Parkinson’s symptoms show, zeroing in on vulnerable brain proteins. Their early ...

Cellular antennae. About 25% of Parkinson's disease cases are caused by genetic mutations, and the single genetic mutation that makes the LRRK2 enzyme too active is one of the most common.. An ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

LIVING near a golf course might come with more than just scenic views – it could carry a hidden health risk. A new study has ...